Winter 2009

ZINC is the lowest cost producer of specialty zinc and zinc-based products, benefiting from a unique refining process that allows them to acquire feedstock at a negative cost. Despite recent declines in zinc prices, the …

Pfizer is currently trading at a significantly low valuation of seven to eight times earnings, a stark contrast to its historical trading range of 40 to 50 times earnings. The company has a strong strategy focusing on ma…

Marvel Entertainment is overvalued at $30 due to unconventional financing and accounting practices, as well as declining demand for their films. The company is expected to struggle to generate sufficient box office reven…

ZINC is a low risk stock due to its cheap valuation and strong balance sheet. The company is positioned as a low-cost producer in its industry, and its valuation is currently below liquidation value, likely due to irrati…